| 2.7 |
10.9 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 2.2 |
6.7 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 1.9 |
5.8 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 1.7 |
5.2 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.7 |
5.1 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 1.6 |
8.2 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.6 |
4.8 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 1.4 |
10.9 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 1.3 |
3.8 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 1.3 |
3.8 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 1.2 |
3.7 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.2 |
3.6 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 1.2 |
3.5 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 1.2 |
4.7 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.1 |
3.4 |
GO:0090340 |
positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 1.0 |
4.2 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 1.0 |
3.0 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 1.0 |
3.8 |
GO:0009183 |
purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.9 |
2.8 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.9 |
1.9 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.9 |
6.4 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.9 |
3.6 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.9 |
1.8 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.9 |
5.3 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.9 |
6.1 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.8 |
3.4 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.8 |
10.1 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.8 |
0.8 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.8 |
2.5 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.8 |
1.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.8 |
2.5 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.8 |
3.3 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.8 |
2.4 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.8 |
0.8 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.8 |
2.4 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.8 |
2.4 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.8 |
2.4 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.8 |
4.6 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.8 |
3.0 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.8 |
2.3 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.8 |
3.8 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.7 |
9.7 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.7 |
3.0 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.7 |
3.0 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.7 |
2.2 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.7 |
4.4 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 0.7 |
2.9 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.7 |
5.8 |
GO:0046618 |
drug export(GO:0046618) |
| 0.7 |
2.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.7 |
2.9 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.7 |
4.3 |
GO:0090034 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.7 |
4.9 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.7 |
2.1 |
GO:0043602 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 0.7 |
0.7 |
GO:0098917 |
retrograde trans-synaptic signaling(GO:0098917) |
| 0.7 |
2.0 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.7 |
2.0 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.7 |
2.0 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.7 |
5.9 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.6 |
3.9 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.6 |
2.6 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.6 |
2.5 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.6 |
5.7 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.6 |
2.5 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.6 |
2.5 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.6 |
2.5 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.6 |
1.8 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.6 |
2.5 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.6 |
4.9 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.6 |
1.8 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.6 |
1.8 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.6 |
2.4 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.6 |
0.6 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.6 |
4.2 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.6 |
1.8 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.6 |
2.4 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.6 |
1.8 |
GO:0060381 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.6 |
4.7 |
GO:0045007 |
depurination(GO:0045007) |
| 0.6 |
0.6 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.6 |
1.8 |
GO:2000625 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.6 |
2.3 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.6 |
1.2 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
| 0.6 |
3.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.6 |
1.7 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.6 |
1.7 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.6 |
1.7 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.6 |
2.9 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.6 |
5.7 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.6 |
1.1 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.6 |
2.8 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.6 |
1.7 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.6 |
1.7 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.6 |
3.9 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.5 |
0.5 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.5 |
3.8 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.5 |
4.3 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.5 |
2.1 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.5 |
4.2 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.5 |
2.6 |
GO:1903400 |
L-arginine transmembrane transport(GO:1903400) |
| 0.5 |
8.9 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.5 |
7.3 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.5 |
4.7 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.5 |
7.3 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.5 |
1.6 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.5 |
4.2 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.5 |
3.6 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.5 |
2.1 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.5 |
1.0 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.5 |
3.1 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.5 |
2.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.5 |
2.0 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.5 |
5.1 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.5 |
5.1 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.5 |
1.5 |
GO:0050823 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.5 |
2.0 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.5 |
5.9 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.5 |
0.5 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.5 |
2.0 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.5 |
1.9 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.5 |
2.9 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.5 |
1.0 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.5 |
1.4 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.5 |
2.4 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.5 |
7.1 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.5 |
1.9 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.5 |
6.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.5 |
3.3 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.5 |
4.7 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.5 |
6.1 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.5 |
1.9 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.5 |
2.4 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.5 |
0.9 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.5 |
14.5 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.5 |
0.5 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.5 |
0.5 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.5 |
1.8 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.5 |
0.9 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.5 |
2.3 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.5 |
1.8 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.5 |
0.9 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.5 |
0.9 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.5 |
1.8 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.4 |
1.3 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 |
1.8 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.4 |
9.8 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.4 |
2.2 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.4 |
4.0 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.4 |
2.7 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.4 |
1.3 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.4 |
1.3 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.4 |
1.3 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.4 |
3.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 |
1.3 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.4 |
1.7 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.4 |
3.4 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) negative regulation of protein glycosylation(GO:0060051) |
| 0.4 |
6.0 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.4 |
0.4 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.4 |
0.4 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.4 |
2.6 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
3.4 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.4 |
1.7 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.4 |
0.8 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.4 |
3.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 |
2.1 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.4 |
1.2 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.4 |
2.9 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.4 |
0.8 |
GO:0060490 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.4 |
2.8 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.4 |
1.6 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.4 |
0.4 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.4 |
2.0 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.4 |
0.4 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.4 |
1.2 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.4 |
8.0 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.4 |
1.6 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 0.4 |
0.4 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.4 |
2.3 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.4 |
0.8 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.4 |
1.9 |
GO:0019427 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.4 |
0.8 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.4 |
0.8 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
| 0.4 |
5.7 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.4 |
2.3 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.4 |
1.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 |
1.1 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.4 |
0.4 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.4 |
1.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.4 |
0.4 |
GO:0071106 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.4 |
3.0 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.4 |
3.4 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.4 |
1.1 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.4 |
2.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.4 |
0.4 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.4 |
1.9 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.4 |
2.6 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.4 |
0.7 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.4 |
3.3 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.4 |
4.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.4 |
0.4 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 |
0.7 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.4 |
1.8 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 |
4.0 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.4 |
5.1 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.4 |
0.7 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.4 |
1.8 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.4 |
1.1 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.4 |
0.4 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.4 |
3.6 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.4 |
1.4 |
GO:0007070 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.4 |
0.7 |
GO:0061289 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.4 |
2.1 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.4 |
2.1 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.4 |
1.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.4 |
2.8 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.4 |
1.1 |
GO:0045553 |
TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.3 |
2.8 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.3 |
2.1 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.3 |
1.0 |
GO:0051040 |
regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.3 |
0.3 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.3 |
1.0 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.3 |
1.7 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 |
0.7 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.3 |
1.7 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.3 |
4.4 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.3 |
1.0 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.3 |
1.0 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.3 |
3.3 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.3 |
2.0 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.3 |
0.7 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 |
1.7 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.3 |
0.7 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.3 |
5.3 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.3 |
2.3 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.3 |
1.3 |
GO:0036483 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.3 |
0.3 |
GO:0001755 |
neural crest cell migration(GO:0001755) |
| 0.3 |
1.0 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.3 |
0.3 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 |
1.6 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.3 |
0.6 |
GO:2000338 |
chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
| 0.3 |
1.0 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.3 |
1.0 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 |
1.0 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.3 |
1.0 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.3 |
1.6 |
GO:0036512 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.3 |
1.3 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.3 |
1.2 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.3 |
0.9 |
GO:1900098 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) regulation of lactation(GO:1903487) positive regulation of lactation(GO:1903489) |
| 0.3 |
1.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.3 |
1.9 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.3 |
0.9 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.3 |
3.4 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.3 |
1.2 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.3 |
2.1 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
0.6 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.3 |
2.7 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
1.2 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.3 |
0.9 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.3 |
0.9 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 |
2.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.3 |
1.2 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.3 |
0.6 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.3 |
10.7 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 |
0.9 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.3 |
0.3 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.3 |
1.8 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.3 |
1.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 |
1.2 |
GO:0072186 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.3 |
1.2 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.3 |
0.9 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.3 |
1.5 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 |
1.5 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.3 |
4.6 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.3 |
0.6 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.3 |
2.0 |
GO:0036343 |
psychomotor behavior(GO:0036343) |
| 0.3 |
3.2 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 |
0.3 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.3 |
1.4 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.3 |
1.7 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.3 |
1.4 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.3 |
1.1 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.3 |
1.4 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.3 |
2.8 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.3 |
0.3 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.3 |
2.2 |
GO:0002005 |
angiotensin catabolic process in blood(GO:0002005) |
| 0.3 |
0.6 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.3 |
1.4 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.3 |
0.6 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.3 |
0.8 |
GO:0060697 |
positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.3 |
1.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.3 |
1.9 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.3 |
3.0 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 |
0.8 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.3 |
2.2 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.3 |
1.6 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.3 |
2.2 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.3 |
0.3 |
GO:0009750 |
response to fructose(GO:0009750) |
| 0.3 |
0.8 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.3 |
1.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.3 |
0.8 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.3 |
0.3 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.3 |
1.1 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.3 |
4.3 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.3 |
6.7 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.3 |
0.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.3 |
1.1 |
GO:2000809 |
positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.3 |
0.5 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.3 |
1.8 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 |
3.7 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.3 |
2.6 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.3 |
1.0 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.3 |
0.3 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 |
1.8 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.3 |
0.5 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.3 |
3.9 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.3 |
1.6 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 |
2.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.3 |
0.3 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.3 |
1.3 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.3 |
0.3 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.3 |
0.5 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.3 |
1.0 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.3 |
0.8 |
GO:0070091 |
glucagon secretion(GO:0070091) |
| 0.3 |
1.3 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.3 |
0.3 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.3 |
0.3 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.3 |
3.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.3 |
1.0 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.3 |
1.0 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.3 |
0.5 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 0.3 |
1.3 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 |
1.0 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 |
6.3 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
0.3 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.3 |
2.8 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.3 |
1.8 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.3 |
1.0 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.3 |
0.8 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
6.0 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.2 |
1.2 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.2 |
0.7 |
GO:2000722 |
regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) |
| 0.2 |
1.7 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
7.8 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.2 |
2.2 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.2 |
1.0 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.2 |
0.7 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.2 |
5.6 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.2 |
1.2 |
GO:1903615 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.2 |
4.8 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.2 |
1.2 |
GO:0002155 |
regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.2 |
2.6 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
1.7 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.2 |
2.2 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.2 |
1.2 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.2 |
0.5 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.2 |
2.6 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
1.9 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.2 |
2.1 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.2 |
0.5 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.2 |
0.7 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.2 |
0.7 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.2 |
1.9 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 |
0.7 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
0.7 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.2 |
1.4 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
1.2 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 |
0.9 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.2 |
1.6 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.2 |
1.8 |
GO:0003342 |
proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.2 |
1.6 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.2 |
3.4 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.2 |
0.2 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.2 |
0.9 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.2 |
0.7 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 |
0.5 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 |
1.6 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.2 |
0.9 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.2 |
0.9 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.2 |
12.2 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
0.9 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 |
0.9 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.2 |
1.3 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 |
1.3 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 |
0.9 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.2 |
0.7 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
0.4 |
GO:0045415 |
negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.2 |
0.7 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 |
0.4 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.2 |
0.6 |
GO:0019082 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.2 |
1.9 |
GO:0019184 |
glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.2 |
0.6 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.2 |
0.4 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 |
1.7 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.2 |
1.7 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 |
0.4 |
GO:1990641 |
response to iron ion starvation(GO:1990641) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.2 |
0.6 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.2 |
0.2 |
GO:0010915 |
regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.2 |
0.6 |
GO:0030806 |
negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.2 |
0.2 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.2 |
0.8 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.2 |
0.6 |
GO:0071901 |
negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.2 |
5.7 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 |
2.9 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
0.2 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 |
0.6 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.2 |
0.4 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.2 |
1.5 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.2 |
0.6 |
GO:2000547 |
regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.2 |
1.0 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
0.2 |
GO:0003164 |
His-Purkinje system development(GO:0003164) |
| 0.2 |
0.8 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
1.4 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.2 |
0.2 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.2 |
2.7 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.2 |
2.5 |
GO:0051597 |
response to methylmercury(GO:0051597) |
| 0.2 |
3.5 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 |
0.8 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 |
0.2 |
GO:0071332 |
cellular response to fructose stimulus(GO:0071332) |
| 0.2 |
0.4 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 |
0.8 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
1.0 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
3.0 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.2 |
0.8 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.2 |
0.2 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.2 |
1.8 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 0.2 |
8.0 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.2 |
0.8 |
GO:0045209 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.2 |
1.0 |
GO:0042747 |
circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.2 |
0.8 |
GO:2001076 |
thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.2 |
1.2 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.2 |
0.6 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.2 |
1.4 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.2 |
0.4 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.2 |
0.4 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 |
0.8 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 |
0.4 |
GO:0042853 |
L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.2 |
0.2 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.2 |
4.5 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 |
0.4 |
GO:0034971 |
histone H3-R17 methylation(GO:0034971) |
| 0.2 |
1.8 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.2 |
1.0 |
GO:0050668 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.2 |
2.7 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.2 |
2.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.2 |
1.3 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 |
0.6 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.2 |
0.6 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.2 |
0.8 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.2 |
7.8 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.2 |
0.6 |
GO:1904030 |
negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.2 |
0.9 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.2 |
1.1 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.2 |
0.8 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.2 |
0.6 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.2 |
0.9 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.2 |
0.4 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.2 |
0.4 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 |
0.6 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
3.7 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 |
0.4 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 |
1.8 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 |
0.4 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.2 |
1.1 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 |
0.4 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.2 |
1.1 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 |
0.5 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.2 |
0.5 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.2 |
2.4 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.2 |
4.5 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 |
0.9 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.2 |
1.6 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
0.2 |
GO:0097017 |
renal protein absorption(GO:0097017) |
| 0.2 |
1.3 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.2 |
0.7 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.2 |
3.8 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
1.3 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
1.8 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 |
0.5 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 |
6.4 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 |
0.9 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.2 |
2.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.2 |
2.7 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 |
1.4 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 |
0.5 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 |
0.2 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) |
| 0.2 |
0.4 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.2 |
1.7 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.2 |
4.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.2 |
0.2 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.2 |
0.5 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 |
1.0 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.2 |
12.3 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
0.2 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.2 |
1.2 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.2 |
3.4 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.2 |
2.7 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) |
| 0.2 |
3.2 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.2 |
0.3 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.2 |
0.8 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.2 |
1.0 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.2 |
0.5 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.2 |
2.9 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.2 |
2.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.2 |
0.8 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 |
0.2 |
GO:0032228 |
regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.2 |
1.8 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.2 |
2.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
0.2 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.2 |
0.3 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.2 |
0.2 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.2 |
5.7 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.2 |
1.0 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.2 |
2.3 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.2 |
0.2 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.2 |
0.7 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
1.8 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.2 |
0.3 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.2 |
0.5 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.2 |
0.3 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.2 |
1.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
0.5 |
GO:0014736 |
regulation of muscle atrophy(GO:0014735) negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.2 |
2.1 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.2 |
0.3 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
1.1 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
0.2 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
1.1 |
GO:2000538 |
regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.2 |
0.8 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 |
0.6 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
1.9 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.2 |
2.2 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.6 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 |
0.2 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.2 |
0.6 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 |
1.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.2 |
9.5 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.2 |
0.5 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 |
0.2 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.2 |
1.1 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.2 |
0.8 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.2 |
0.5 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.2 |
2.0 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.2 |
2.0 |
GO:0006206 |
pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.2 |
1.7 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.2 |
0.5 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.1 |
0.4 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.1 |
0.1 |
GO:0035905 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.1 |
0.6 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.1 |
1.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
1.2 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.9 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.9 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
1.0 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.9 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.1 |
1.3 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.1 |
1.6 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.1 |
3.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
2.9 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.9 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
0.3 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.9 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.1 |
0.9 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.6 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
1.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.4 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
2.2 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
2.5 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.3 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.1 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
0.3 |
GO:0010224 |
response to UV-B(GO:0010224) |
| 0.1 |
22.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.4 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 |
0.1 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.1 |
0.1 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.1 |
0.8 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.1 |
0.7 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.1 |
3.9 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 |
1.3 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
1.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.3 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.1 |
2.5 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.8 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.1 |
0.3 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
1.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.1 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.5 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 |
0.1 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.1 |
1.2 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
2.1 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.8 |
GO:0031179 |
peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.1 |
0.1 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.1 |
0.3 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.1 |
1.1 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.4 |
GO:0072081 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.1 |
0.8 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 |
2.7 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.7 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 |
0.1 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.1 |
0.5 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.1 |
0.5 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
1.1 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.4 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.7 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.1 |
0.7 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 |
0.3 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
2.6 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
5.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.1 |
GO:0061525 |
hindgut development(GO:0061525) |
| 0.1 |
0.3 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.1 |
GO:1900048 |
positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 0.1 |
0.7 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.6 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 |
0.5 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.8 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.1 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
0.4 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.1 |
1.4 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 |
0.8 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
1.3 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
0.6 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
2.9 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
3.2 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.1 |
0.9 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.3 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.1 |
0.6 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.9 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.6 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.1 |
0.6 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
1.0 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.1 |
2.5 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
1.4 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.1 |
0.7 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.6 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.2 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.6 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.1 |
0.5 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.2 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.1 |
1.7 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.1 |
0.2 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.4 |
GO:0035787 |
cell migration involved in kidney development(GO:0035787) |
| 0.1 |
1.0 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.5 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.7 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.2 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.1 |
1.3 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.1 |
1.2 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.4 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.1 |
0.2 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.4 |
GO:0046081 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.1 |
0.6 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
0.6 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.8 |
GO:0030320 |
cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.1 |
1.1 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
1.8 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.6 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.1 |
0.2 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.1 |
0.7 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
0.6 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 |
7.1 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
0.5 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.2 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.1 |
0.6 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.1 |
0.8 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
0.7 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.1 |
0.7 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
0.6 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
1.4 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.1 |
GO:1903401 |
L-lysine transmembrane transport(GO:1903401) |
| 0.1 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.6 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 |
0.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.1 |
GO:0038061 |
NIK/NF-kappaB signaling(GO:0038061) |
| 0.1 |
0.9 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.1 |
1.2 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.7 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.2 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.1 |
0.4 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
1.1 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.1 |
0.3 |
GO:0006612 |
protein targeting to membrane(GO:0006612) |
| 0.1 |
0.2 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.1 |
2.9 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.1 |
0.3 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.1 |
1.8 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.1 |
0.2 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
2.0 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.1 |
0.1 |
GO:1990791 |
dorsal root ganglion development(GO:1990791) |
| 0.1 |
9.4 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
1.9 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
0.2 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.1 |
0.3 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.1 |
8.5 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.4 |
GO:0097479 |
synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
| 0.1 |
0.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.5 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
0.1 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.5 |
GO:0036378 |
calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.1 |
0.4 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.1 |
0.1 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 |
0.3 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.3 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.1 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.1 |
0.3 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.1 |
1.5 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
1.5 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.8 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
0.3 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 |
0.3 |
GO:0072141 |
renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.1 |
0.9 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.4 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.1 |
0.3 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.1 |
2.1 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.1 |
0.5 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.3 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.1 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
2.4 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.6 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.1 |
1.4 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.4 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.1 |
0.1 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
1.0 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.1 |
0.1 |
GO:1904397 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.1 |
0.3 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 |
1.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
1.2 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
0.4 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 |
0.5 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 |
0.4 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.3 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.1 |
1.9 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.1 |
0.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.4 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.3 |
GO:0051167 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
1.5 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.1 |
0.9 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
2.2 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 |
1.1 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.8 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
1.5 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.7 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
1.2 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 |
0.5 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
1.0 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.3 |
GO:0033598 |
mammary gland epithelial cell proliferation(GO:0033598) |
| 0.1 |
0.3 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
0.3 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.1 |
1.3 |
GO:0045922 |
negative regulation of fatty acid metabolic process(GO:0045922) |
| 0.1 |
0.1 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 |
0.9 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
0.3 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.1 |
0.5 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 |
0.5 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
0.6 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 |
0.5 |
GO:0060177 |
regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.2 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 |
0.6 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
0.2 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.1 |
0.3 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
0.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 |
0.3 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.2 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.4 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.2 |
GO:0015874 |
norepinephrine transport(GO:0015874) norepinephrine secretion(GO:0048243) |
| 0.1 |
0.9 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.1 |
0.4 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 |
0.3 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 |
0.5 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
0.4 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.1 |
0.4 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 |
0.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.4 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.3 |
GO:0014888 |
striated muscle adaptation(GO:0014888) |
| 0.1 |
0.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.4 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.3 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
1.4 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
0.3 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.1 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
1.9 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
2.0 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 |
0.3 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
2.7 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.6 |
GO:0070304 |
positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
| 0.1 |
0.2 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.1 |
2.1 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.1 |
0.4 |
GO:2000406 |
positive regulation of T cell migration(GO:2000406) |
| 0.1 |
0.2 |
GO:0003151 |
outflow tract morphogenesis(GO:0003151) |
| 0.1 |
0.4 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.1 |
0.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.1 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.1 |
0.1 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.1 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.2 |
GO:0046066 |
dGDP metabolic process(GO:0046066) |
| 0.1 |
0.1 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 |
0.4 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.1 |
0.2 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 |
0.3 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.1 |
0.5 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
0.2 |
GO:0040023 |
establishment of nucleus localization(GO:0040023) |
| 0.1 |
0.2 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.1 |
0.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.1 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 |
0.3 |
GO:0042144 |
vacuole fusion, non-autophagic(GO:0042144) |
| 0.1 |
6.6 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
0.4 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.4 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.1 |
2.1 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 |
0.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.2 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
0.4 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.1 |
0.3 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 |
0.1 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
| 0.1 |
0.2 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
0.9 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.1 |
GO:0035437 |
maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 |
0.3 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.1 |
GO:2000506 |
negative regulation of energy homeostasis(GO:2000506) |
| 0.1 |
0.3 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.1 |
0.2 |
GO:0048753 |
pigment granule organization(GO:0048753) |
| 0.1 |
0.2 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 |
0.2 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 |
0.4 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.1 |
0.2 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.1 |
0.2 |
GO:0072216 |
positive regulation of metanephros development(GO:0072216) |
| 0.1 |
2.0 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
1.1 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 |
3.6 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.2 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.6 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.1 |
0.5 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
0.1 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
0.1 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.3 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
0.3 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.1 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 0.1 |
0.2 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.1 |
1.3 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
0.2 |
GO:0071350 |
interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 0.1 |
0.1 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.1 |
0.9 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.2 |
GO:0046203 |
spermidine catabolic process(GO:0046203) |
| 0.1 |
0.6 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 |
0.1 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.1 |
1.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.5 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.2 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.1 |
3.0 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.1 |
0.2 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.4 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 |
0.5 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 |
0.4 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 |
0.5 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
6.0 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.3 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.1 |
0.1 |
GO:0034127 |
regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
| 0.1 |
0.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.1 |
0.2 |
GO:0031064 |
negative regulation of histone deacetylation(GO:0031064) |
| 0.1 |
3.3 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.1 |
0.7 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.1 |
0.2 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
| 0.1 |
0.5 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.1 |
1.0 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.8 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.1 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 |
0.3 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 |
0.3 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.1 |
0.8 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.3 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.3 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.1 |
0.9 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 |
0.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.3 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.1 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.1 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 |
0.1 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.1 |
1.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.9 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
0.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.6 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 |
0.1 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.1 |
0.1 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.1 |
1.7 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 |
0.9 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
0.4 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
0.3 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.3 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.1 |
0.1 |
GO:1904995 |
negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 |
0.2 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
0.3 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.2 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.1 |
0.3 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.1 |
0.1 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.1 |
0.1 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 |
0.2 |
GO:0002034 |
regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.1 |
0.2 |
GO:0031054 |
pre-miRNA processing(GO:0031054) |
| 0.1 |
0.2 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
1.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.1 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.1 |
1.1 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.4 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 |
0.2 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 |
0.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.1 |
1.3 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
2.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.3 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 |
0.1 |
GO:0002353 |
kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.1 |
0.2 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
7.4 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
1.0 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.1 |
0.3 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
1.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.2 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.1 |
0.2 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.7 |
GO:0044597 |
polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.4 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.3 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.1 |
0.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
1.1 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
2.1 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 |
0.3 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.2 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
0.2 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
0.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.1 |
0.2 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
0.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.1 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.1 |
0.2 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.2 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 |
0.5 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.4 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 |
1.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.2 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.3 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 |
0.3 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
0.3 |
GO:2000178 |
negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.1 |
1.2 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
2.4 |
GO:0046323 |
glucose import(GO:0046323) |
| 0.1 |
0.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.1 |
GO:0010665 |
regulation of cardiac muscle cell apoptotic process(GO:0010665) |
| 0.1 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.3 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
0.1 |
GO:0002514 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.1 |
0.1 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.1 |
0.3 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 |
1.5 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.1 |
0.1 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
2.5 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 |
1.4 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.5 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.1 |
0.1 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
0.5 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.1 |
0.2 |
GO:0021825 |
substrate-dependent cerebral cortex tangential migration(GO:0021825) |
| 0.1 |
0.4 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.1 |
0.1 |
GO:0021514 |
ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.1 |
0.1 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.1 |
1.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.2 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.1 |
0.2 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 |
0.3 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
1.0 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.3 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 |
0.5 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.1 |
0.3 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 |
0.5 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.6 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
1.5 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.1 |
0.2 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.1 |
0.5 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.2 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.1 |
GO:1901858 |
regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.1 |
0.3 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
0.1 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
1.1 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.1 |
0.1 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 |
0.3 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.1 |
0.2 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 |
0.3 |
GO:2000504 |
negative regulation of Fas signaling pathway(GO:1902045) positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.2 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.1 |
GO:2001057 |
reactive nitrogen species metabolic process(GO:2001057) |
| 0.1 |
0.6 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.5 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 |
0.4 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.4 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.1 |
0.3 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.1 |
3.8 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.4 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.0 |
0.1 |
GO:0014858 |
positive regulation of skeletal muscle cell proliferation(GO:0014858) |
| 0.0 |
0.1 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.0 |
GO:0090382 |
phagosome maturation(GO:0090382) |
| 0.0 |
0.1 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
0.4 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
| 0.0 |
0.0 |
GO:0046460 |
triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.0 |
0.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 |
0.3 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.0 |
0.4 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.4 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.0 |
0.8 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.4 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.0 |
0.4 |
GO:1901160 |
primary amino compound metabolic process(GO:1901160) |
| 0.0 |
0.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.8 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.3 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.3 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.1 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.3 |
GO:0019556 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
0.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
0.2 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.0 |
2.1 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.0 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.0 |
0.0 |
GO:1903318 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.0 |
0.4 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.0 |
0.2 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.1 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.0 |
1.7 |
GO:0006779 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.0 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.0 |
0.0 |
GO:0007632 |
visual behavior(GO:0007632) |
| 0.0 |
0.4 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.0 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.0 |
0.0 |
GO:0003207 |
cardiac chamber formation(GO:0003207) |
| 0.0 |
0.1 |
GO:0042435 |
indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.0 |
2.4 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 |
0.2 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
1.8 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.1 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 |
0.1 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.0 |
1.1 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
1.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0032714 |
negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) |
| 0.0 |
0.3 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 |
0.2 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.0 |
0.2 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.2 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 |
0.1 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 |
0.5 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.0 |
0.6 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 |
0.2 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.0 |
0.2 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
| 0.0 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.2 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.0 |
1.0 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.3 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.6 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.1 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.0 |
0.6 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.0 |
0.2 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.0 |
0.1 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) |
| 0.0 |
0.0 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.0 |
0.1 |
GO:1904396 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of neuromuscular junction development(GO:1904396) |
| 0.0 |
1.4 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
1.1 |
GO:0016575 |
histone deacetylation(GO:0016575) |
| 0.0 |
0.2 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
4.2 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.2 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.0 |
0.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 |
0.5 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.1 |
GO:0001763 |
morphogenesis of a branching structure(GO:0001763) |
| 0.0 |
0.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.0 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.0 |
0.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.1 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.0 |
0.8 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.8 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 |
0.0 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.0 |
0.3 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.0 |
0.1 |
GO:0009953 |
dorsal/ventral pattern formation(GO:0009953) |
| 0.0 |
0.4 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.2 |
GO:0014721 |
voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
| 0.0 |
0.1 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.0 |
0.2 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.0 |
0.1 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.0 |
0.1 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.0 |
0.9 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.5 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.3 |
GO:0031269 |
pseudopodium assembly(GO:0031269) |
| 0.0 |
0.0 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.0 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.0 |
1.9 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.1 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.0 |
0.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 |
0.1 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.0 |
0.1 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 |
0.0 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.0 |
0.6 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
2.1 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 |
2.8 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 |
0.1 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.0 |
0.1 |
GO:2001239 |
regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
| 0.0 |
0.3 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.0 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.1 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.0 |
0.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.0 |
GO:0060038 |
cardiac muscle cell proliferation(GO:0060038) |
| 0.0 |
0.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.0 |
0.1 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.3 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.0 |
0.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.0 |
1.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.0 |
0.2 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.0 |
0.3 |
GO:0032888 |
regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.0 |
0.1 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.7 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 |
0.0 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.0 |
0.1 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.0 |
0.0 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.0 |
GO:0046886 |
positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.0 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.9 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 |
0.1 |
GO:0034381 |
plasma lipoprotein particle clearance(GO:0034381) |
| 0.0 |
0.0 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.0 |
0.3 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.0 |
0.1 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.0 |
0.2 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.3 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
0.0 |
GO:1903121 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
| 0.0 |
0.1 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.0 |
0.0 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 |
0.0 |
GO:0010759 |
regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 |
0.4 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 |
0.1 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.0 |
0.2 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.0 |
0.6 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
0.4 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.2 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.0 |
0.0 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.1 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.0 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.0 |
0.2 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) |
| 0.0 |
0.1 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.0 |
0.0 |
GO:0030111 |
regulation of Wnt signaling pathway(GO:0030111) |
| 0.0 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
0.1 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 |
0.1 |
GO:0030473 |
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.0 |
0.3 |
GO:0051216 |
cartilage development(GO:0051216) |
| 0.0 |
0.8 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 |
0.2 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
1.4 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.4 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
0.6 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.0 |
0.1 |
GO:0070572 |
positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 |
0.1 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.1 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.0 |
0.1 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.0 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.0 |
0.1 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.2 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.0 |
0.1 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.0 |
0.1 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.0 |
0.1 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 |
0.5 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.6 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.0 |
0.5 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.3 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.0 |
0.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
0.1 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.0 |
0.3 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.2 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.0 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.1 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.0 |
0.0 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.0 |
0.2 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
0.1 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.2 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.0 |
0.0 |
GO:1900365 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 |
0.4 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.0 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.5 |
GO:0006684 |
sphingomyelin metabolic process(GO:0006684) |
| 0.0 |
0.3 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 |
0.3 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.0 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.0 |
0.2 |
GO:0072010 |
glomerular epithelium development(GO:0072010) |
| 0.0 |
0.2 |
GO:0051384 |
response to glucocorticoid(GO:0051384) |
| 0.0 |
0.0 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.5 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.3 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.2 |
GO:0032753 |
positive regulation of interleukin-4 production(GO:0032753) |
| 0.0 |
0.3 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.2 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.2 |
GO:0032656 |
interleukin-13 production(GO:0032616) regulation of interleukin-13 production(GO:0032656) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.0 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.0 |
0.1 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 |
0.1 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.0 |
0.1 |
GO:0010922 |
positive regulation of phosphatase activity(GO:0010922) |
| 0.0 |
0.2 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.3 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.1 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
2.3 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.1 |
GO:0050686 |
negative regulation of mRNA processing(GO:0050686) |
| 0.0 |
0.0 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.0 |
0.2 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 |
0.1 |
GO:0038042 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.0 |
0.2 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.0 |
0.1 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.0 |
0.4 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.1 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.0 |
0.0 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.0 |
0.0 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 |
0.8 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.0 |
0.1 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.0 |
0.1 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 |
0.1 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.1 |
GO:0007588 |
excretion(GO:0007588) |
| 0.0 |
0.1 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.0 |
0.7 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.5 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 |
0.0 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.0 |
0.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.4 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
0.2 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.2 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.1 |
GO:0021997 |
neural plate axis specification(GO:0021997) |
| 0.0 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:0019430 |
removal of superoxide radicals(GO:0019430) |
| 0.0 |
0.1 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.0 |
0.0 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.4 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.1 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.0 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.0 |
0.0 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.0 |
0.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.0 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.0 |
0.1 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 |
0.0 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.0 |
0.3 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.1 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 |
0.0 |
GO:0051784 |
negative regulation of nuclear division(GO:0051784) |
| 0.0 |
0.1 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.0 |
0.5 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.1 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.0 |
0.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.1 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 |
0.3 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.0 |
0.1 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.0 |
0.3 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.0 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 |
0.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.0 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.0 |
0.1 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.0 |
0.1 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.0 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 |
0.0 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 |
0.0 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
0.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.0 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 |
0.0 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.0 |
GO:1900363 |
regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 |
0.1 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.0 |
0.1 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 |
0.1 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.0 |
GO:0009180 |
purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.0 |
0.3 |
GO:1901222 |
regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 |
0.2 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.0 |
0.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.1 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.1 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.0 |
0.1 |
GO:0097369 |
sodium ion import(GO:0097369) |
| 0.0 |
0.7 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.0 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.1 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.0 |
0.2 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.0 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.0 |
0.3 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.1 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.1 |
GO:0070977 |
bone maturation(GO:0070977) |
| 0.0 |
0.0 |
GO:0001823 |
mesonephros development(GO:0001823) |
| 0.0 |
0.1 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.0 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.0 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 |
0.0 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.0 |
0.0 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.0 |
0.1 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.0 |
0.0 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.0 |
0.1 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.0 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
0.0 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.0 |
0.0 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) divalent metal ion export(GO:0070839) |
| 0.0 |
0.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 |
0.0 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.0 |
0.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.0 |
0.1 |
GO:0014733 |
regulation of skeletal muscle adaptation(GO:0014733) |
| 0.0 |
0.0 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.0 |
0.0 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.0 |
0.1 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.0 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.0 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.0 |
0.0 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 |
0.1 |
GO:0061213 |
positive regulation of mesonephros development(GO:0061213) |
| 0.0 |
0.0 |
GO:0060174 |
regulation of collateral sprouting in absence of injury(GO:0048696) limb bud formation(GO:0060174) |
| 0.0 |
0.0 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.0 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
